These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2261914)

  • 21. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.
    Brierley J; Tsang R; Panzarella T; Bana N
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
    Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
    Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insular thyroid carcinoma: collective analysis of clinicohistologic prognostic factors and treatment effect with radioiodine or radiation therapy.
    Lai HW; Lee CH; Chen JY; Tseng LM; Yang AH
    J Am Coll Surg; 2006 Nov; 203(5):715-22. PubMed ID: 17084334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dosimetric measurements and early complications in patients with differentiated thyroid carcinomas treated with radioactive iodine].
    Malesević M; Stefanović L; Adzić O; Mihoci Z; Elez D
    Med Pregl; 1992; 45(11-12):427-31. PubMed ID: 1344442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting outcome and directing therapy for papillary thyroid carcinoma.
    Kim S; Wei JP; Braveman JM; Brams DM
    Arch Surg; 2004 Apr; 139(4):390-4; discussion 393-4. PubMed ID: 15078706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pure follicular thyroid carcinoma: impact of therapy in 214 patients.
    Young RL; Mazzaferri EL; Rahe AJ; Dorfman SG
    J Nucl Med; 1980 Aug; 21(8):733-7. PubMed ID: 7400828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
    Cheema Y; Olson S; Elson D; Chen H
    J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
    Chow SM; Yau S; Kwan CK; Poon PC; Law SC
    Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era.
    Capdevila J; Argiles G; Rodriguez-Frexinos V; Nuñez I; Tabernero J
    Discov Med; 2010 Feb; 9(45):153-62. PubMed ID: 20193642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial radioiodine administration: when to use it and how to select the dose.
    Esposito G
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thyroid function following radioiodine resection of autonomous thyroid adenomas].
    Heinze HG; Pickardt CR; Swoboda G; Horn K; Erhardt F; Scriba PC
    Nuklearmedizin; 1977 Oct; 16(5):224-31. PubMed ID: 593905
    [No Abstract]   [Full Text] [Related]  

  • 32. Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update.
    Ciarallo A; Rivera J
    AJR Am J Roentgenol; 2020 Aug; 215(2):285-291. PubMed ID: 32551904
    [No Abstract]   [Full Text] [Related]  

  • 33. A Matter of Controversy: Is Radioiodine Therapy Favorable in Differentiated Thyroid Carcinoma?
    Schmidt M; Görges R; Drzezga A; Dietlein M
    J Nucl Med; 2018 Aug; 59(8):1195-1201. PubMed ID: 29748234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [13II therapy of metastatic carcinoma of thyroid (author's transl)].
    Ma J
    Zhonghua Fang She Xue Za Zhi; 1979; 13(4):228-32. PubMed ID: 162412
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy.
    Murcutt G; Edwards J; Boakye J; Davenport A
    Kidney Int; 2008 Jun; 73(11):1316-9. PubMed ID: 18354377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of radioactive iodine I-131 and monitoring of radioactivity in patients with chronic kidney disease on haemodialysis.
    Gallegos-Villalobos A; García-López F; Escalada C; Ortiz JJ; Cardona J; Medina A; Portolés J
    Nefrologia; 2014 May; 34(3):317-22. PubMed ID: 24798564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioiodine therapy a successful tool in treating thyroid cancer. Foreword.
    Bombardieri E; Pacini F
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):439. PubMed ID: 20205316
    [No Abstract]   [Full Text] [Related]  

  • 38. Iodine-refractory thyroid carcinoma.
    Ganti AK; Cohen EE
    Rev Recent Clin Trials; 2006 May; 1(2):133-41. PubMed ID: 18473964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radioiodine in adjuvant therapy for patients with thyroid medullary carcinoma].
    Rosário PW; Fagundes TA
    Arq Bras Endocrinol Metabol; 2004 Dec; 48(6):913-4. PubMed ID: 15761569
    [No Abstract]   [Full Text] [Related]  

  • 40. The risks and benefits of radioiodine therapy for thyroid carcinoma remain somewhat undifferentiated.
    Haugen BR
    Thyroid; 2000 Nov; 10(11):971-3. PubMed ID: 11128724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.